Related Experiment Videos
Hepatic artery embolization: factors predisposing to postembolization pain and nausea
1Department of Radiology, University of Washington School of Medicine, Seattle, USA. nhpatel@iupui.edu
Journal of Vascular and Interventional Radiology : JVIR
|April 29, 2000
Summary
Preprocedural liver function tests and age do not predict pain or nausea after hepatic arterial embolization (HAE). Postembolization pain remains a significant management challenge for physicians.
Area of Science:
- Interventional Radiology
- Oncology
- Pain Management
Background:
- Hepatic arterial embolization (HAE) is a palliative treatment for unresectable liver neoplasms.
- Assessing and managing postembolization pain and nausea is crucial for patient care.
Purpose of the Study:
- To identify preprocedural factors predicting pain and nausea severity after HAE.
- To evaluate the predictive value of liver function tests and patient age.
Main Methods:
- Analysis of 62 patients undergoing 130 palliative lobar HAEs using polyvinyl alcohol particulates.
- Pain and nausea were assessed using validated scales; morphine use was recorded.
- Statistical analysis included ANOVA and Spearman correlation to identify predictors.
Main Results:
- No strong categorical predictors for pain or nausea severity were identified.
- Pre-embolization liver function tests showed significant associations with pain but were not strong individual predictors.
- Morphine requirements strongly correlated with pain scores, but no significant differences were found between first and subsequent embolizations.
Conclusions:
- Laboratory values and patient age do not reliably predict post-HAE pain and nausea.
- Postembolization pain is a significant complication requiring ongoing clinical attention.